1 / 3

Chlamydia Market Insights and Epidemiology Forecast

Chlamydial infection, caused by Chlamydia trachomatis, is the most common bacterial sexually transmitted infection (STI). Age is a strong predictor of risk for chlamydial infections, with the highest infection rates in women occurring during ages 15u201324 years.

xmichael
Download Presentation

Chlamydia Market Insights and Epidemiology Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chlamydia Chlamydial infection, caused by Chlamydia trachomatis, is the most common bacterial sexually transmitted infection (STI). Age is a strong predictor of risk for chlamydial infections, with the highest infection rates in women occurring during ages 15–24 years. As most individuals with the infection are asymptomatic, it is often left untreated, increasing the risk of transmission and serious health consequences in both sexes. Chlamydia Epidemiology Segmentation in the 7MM ● ● ● ● Diagnosed Incident Cases of Chlamydia Gender-specific Cases of Chlamydia Symptom-specific Cases of Chlamydia Age-specific Cases of Chlamydia Chlamydia Epidemiological Insights Observed in the 7MM (2021) ● The total diagnosed incident cases of Chlamydia in the 7MM were found to be 3.4 million in the year 2021. The total diagnosed incident cases of Chlamydia in the US were observed to be 1.9 million in the year 2021. The total diagnosed incident cases of Chlamydia in Germany were estimated to be 446k. ● ● Chlamydia Market Insight The market size of Chlamydia in the 7MM was found to be USD 59.5 million in 2021. Chlamydia Emerging Therapies The emerging drugs in the Chlamydia market are ● ● ● ● EVO100 Chlamydia infection blockers (CIBs) VPI-201 Salmonella-Based Vaccine Chlamydia Key Players The key players working in the Chlamydia market are ● Evofem Biosciences

  2. ● ● ● QureTechBio Vault Pharma Aeterna Zentaris, and several others

More Related